Patents by Inventor Jingxuan Liu

Jingxuan Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240356455
    Abstract: A voltage conversion circuit, a control method, a power supply device, and a storage medium are provided. The circuit may include a fourth switch module, a third switch module, a first switch module, a second switch module and a ground lead which are sequentially connected in series; a first capacitor connected to a first common terminal and a second common terminal respectively; a second capacitor connected to a power output terminal and a ground lead; a driving module configured to regulate an initial duty ratio of a driving signal for each of the first to fourth switch modules, based on a capacitor voltage of both ends of the first capacitor; and an inductor connected with a power input terminal and a third common terminal respectively, or connected with the third common terminal and the power output terminal respectively.
    Type: Application
    Filed: July 8, 2022
    Publication date: October 24, 2024
    Inventors: Rundong LIU, Hong WANG, Jianping ZHOU, Jingxuan ZHOU, Zhexu LI, Lingsong YI
  • Publication number: 20240322589
    Abstract: Embodiments of the present application provide a charging control method and a charging control apparatus of a lithium-ion battery. The charging control method includes: performing charging control on the lithium-ion battery for the ith time, so that a battery capacity value of the lithium-ion battery at a target charging cut-off voltage is 0.95C0 to 1.05C0, where C0 is a nominal capacity of the lithium-ion battery, and the target charging cut-off voltage is less than or equal to the nominal voltage of the lithium-ion battery. The charging control method and the charging control apparatus according to the embodiments of the present application are beneficial to keeping the quantity of active lithium unchanged, thereby achieving the effect of automatically supplementing the battery capacity along with aging.
    Type: Application
    Filed: May 23, 2024
    Publication date: September 26, 2024
    Applicant: CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED
    Inventors: Xiaofu Xu, Yibo Shang, Jianfu Pan, Jingxuan Sun, Qian Liu, Yonghuang Ye
  • Patent number: 12077602
    Abstract: IgG epitope and applications thereof as a target are provided. The IgG epitope is the CH1 domain of non-B cell-derived IgG, and there is N-glycosylated sialic acid modification at the Asn162 site of the domain. The realization of its antigen functions must depend on the sialylation of the site. The present invention further discloses the applications of the IgG epitope as a drug target in preparing drugs for diagnosis and/or treatment of epithelial tumors. In addition, our studies showed that this antigen depends on the sialylation of Asn162 site as a drug target, and the sialylation of this site must depend on sialyltransferase ST3GAL4, indicating that the enzyme can be used as a drug target for preparing tumor therapeutic drugs. Further, integrin ?4 is co-expressed and co-localized with IgG containing the epitope. IgG can be used as a marker for preparing drugs for the auxiliary detection of epithelial tumors.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: September 3, 2024
    Assignee: Beijing SIG Biopharmaceutical Technology Co., Ltd.
    Inventors: Xiaoyan Qiu, Jingshu Tang, Zhi Yang, Chong Wang, Jingxuan Zhang, Hua Zhu, Zihan Geng, Yang Liu, Wenhua Jiang, Jing Huang
  • Publication number: 20240254482
    Abstract: The present invention relates to methods of use of RNAi agents, e.g., double stranded RNAi agents, targeting a Factor XII (Hageman Factor (F12) gene, for treating subjects having a contact activation pathway-associated disease, such as a thrombophilia or hereditary angioedema (HAE), methods for preventing at least one symptom in a subject having a contact activation pathway-associated disease, such as a thrombus formation or an angioedema attack, and RNAi agents targeting an F12 gene, for use in the methods of the invention.
    Type: Application
    Filed: August 17, 2023
    Publication date: August 1, 2024
    Inventors: James Butler, Jingxuan Liu
  • Patent number: 12006858
    Abstract: Systems and apparatuses include a system including an electronic compressor, a bypass intake coupled between an engine system of a generator set and the electronic compressor, a bypass outlet coupled between the electronic compressor and the engine system, and a valve positioned to selectively inhibit flow between the bypass intake and the bypass outlet during a starting operation.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: June 11, 2024
    Assignee: Cummins Power Generation IP, Inc.
    Inventors: Trideep Singh, Jingxuan Liu, Veronica Susan Perks, Phillip L. Roach, Carlos Alcides Lana, John C. Stetter, Stephen Cox, Philipe F. Saad, Rick Vaughn Lewis, Jr., Milan Khushal Visaria
  • Publication number: 20240076664
    Abstract: The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting the Kallikrein B, Plasma (Fletcher Factor) 1 (KLKB1) gene, the Factor XII (Hageman Factor (F12) gene, or the Kininogen 1 (KNG1) gene, and methods of using such RNAi agents to inhibit expression of a KLKB1 gene, an F12 gene, and/or a KNG1 gene, and methods of treating subjects having an hereditary angioedema (HAE) and/or a contact activation pathway-associated disorder.
    Type: Application
    Filed: July 5, 2023
    Publication date: March 7, 2024
    Inventors: Akin Akinc, Gregory Hinkle, Martin A. Maier, James Butler, Jingxuan Liu
  • Patent number: 11920509
    Abstract: Systems, methods and apparatus are disclosed for providing reduced engine start times for a fumigation type internal combustion engine. A bypass is provided that directly connects the air-fuel mixer upstream of the compressor to the intake manifold, providing the air-fuel mixture to the intake manifold during engine startup.
    Type: Grant
    Filed: June 22, 2022
    Date of Patent: March 5, 2024
    Assignee: Cummins Inc.
    Inventors: Rick Vaughan Lewis, Jr., Yilun Liu, Jingxuan Liu, Trideep Singh, Carlos Alcides Lana, Stephen Cox
  • Publication number: 20240017702
    Abstract: Devices, systems, and methods for predictive anti-lag braking control for autonomous vehicles are described. An example method of controlling a vehicle includes receiving, from a controller, a first plurality of values indicative of a brake wheel torque demand associated with a deceleration profile of the vehicle, deriving, based on the first plurality of values and a steady-state brake model, a second plurality of values indicative of a brake pressure demand, wherein an input to the steady-state brake model comprises the brake pressure demand and at least one previous brake wheel torque demand, and wherein an output of the steady-state brake system comprises a current brake wheel torque demand, generating, based on the second plurality of values and at least the steady-state model, a plurality of brake control commands, and controlling, using the plurality of brake control commands, the air brake system.
    Type: Application
    Filed: June 26, 2023
    Publication date: January 18, 2024
    Inventors: Junbo JING, Jingxuan LIU, Haimo BI, Arda KURT
  • Publication number: 20230415777
    Abstract: Devices, systems, and methods for estimating wheel torque in an autonomous vehicle include a method for controlling a vehicle includes using a dual filter framework to generate an updated estimate of a wheel torque, and controlling, based on the updated estimate of the wheel torque, the vehicle. A first filter of the dual filter framework is configured to generate a blended estimate of the wheel torque by combining a first estimate of the wheel torque that is generated based on a set of mechanical torque transfer models of at least a powertrain and a brake of the vehicle and a second estimate of wheel torque that is generated based on an inverted longitudinal dynamic model, and a second non-linear filter of the dual filter framework is configured to generate the updated estimate of a wheel torque and vehicle velocity based on a torque delivery damping process model on vehicle motion.
    Type: Application
    Filed: June 26, 2023
    Publication date: December 28, 2023
    Inventors: Jingxuan LIU, Arda KURT, Junbo JING
  • Publication number: 20230278560
    Abstract: A method of operating an electronic control system of a vehicle includes determining a first braking distance to achieve a first speed of a first vehicle, receiving a second vehicle braking distance to achieve a second vehicle speed of a second vehicle forward of the first vehicle, determining a minimum following distance between the first vehicle and the second vehicle in response to the first braking distance and the second braking distance, and controlling operation of the vehicle with an autonomous control system using the minimum following distance. A computer-implemented fleet management system is configured to receive logistics objectives including load, timeline, and cost information for a freight delivery, receive fleet information including tire parameters of a plurality of vehicles of a fleet, and determine a plurality of trips and a corresponding vehicle selection in response to the logistics objectives and the fleet information.
    Type: Application
    Filed: May 11, 2023
    Publication date: September 7, 2023
    Applicants: Cummins Inc., Compagnie Generale Des Etablissements Michelin
    Inventors: Hoseinali Borhan, Jingxuan Liu, Bibin N. Pattel, Robert Ciprian Radulescu
  • Publication number: 20230274648
    Abstract: Systems and apparatuses include one or more processing circuits including one or more memory devices coupled to one or more processors. The one or more memory devices are configured to store instructions thereon that, when executed by the one or more processors, cause the one or more processors to: receive a parameter regarding operation of a first vehicle of a first platoon; compare the parameter to a first predetermined threshold; responsive to determining that the parameter satisfies the first predetermined threshold, determine an exit parameter for the first vehicle; and cause the first vehicle to exit the first platoon based on the exit parameter.
    Type: Application
    Filed: May 8, 2023
    Publication date: August 31, 2023
    Applicant: Cummins Inc.
    Inventors: Vivek Anand Sujan, Phani Kiran Vajapeyazula, Govindarajan Kothandaraman, Jingxuan Liu, Kenneth M. Follen
  • Patent number: 11682306
    Abstract: Systems and apparatuses include one or more processing circuits comprising one or more memory devices coupled to one or more processors, the one or more memory devices configured to store instructions thereon that, when executed by the one or more processors, cause the one or more processors to: determine at least one reason for a deserter to exit a first platoon; determine a deserter position within the first platoon; communicate the deserter exit to the first platoon after determination of the at least one reason for the deserter to exit the first platoon based at least in part on the deserter position; adapt a behavior of the first platoon to allow the deserter to exit the first platoon; and reconfigure the remaining vehicles from the first platoon into a second platoon.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: June 20, 2023
    Assignee: Cummins Inc.
    Inventors: Vivek Anand Sujan, Phani Kiran Vajapeyazula, Govindarajan Kothandaraman, Jingxuan Liu, Kenneth M. Follen
  • Publication number: 20230010956
    Abstract: Systems and apparatuses include a system including an electronic compressor, a bypass intake coupled between an engine system of a generator set and the electronic compressor, a bypass outlet coupled between the electronic compressor and the engine system, and a valve positioned to selectively inhibit flow between the bypass intake and the bypass outlet during a starting operation.
    Type: Application
    Filed: December 2, 2020
    Publication date: January 12, 2023
    Applicant: Cummins Power Generation IP, Inc.
    Inventors: Trideep Singh, Jingxuan Liu, Veronica Susan Perks, Phillip L. Roach, Carlos Alcides Lana, John C. Stetter, Stephen Cox, Philipe F. Saad, Rick Vaughn Lewis, Jr., Milan Khushal Visaria
  • Publication number: 20220411801
    Abstract: The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the xanthine dehydrogenase (XDH) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of an XDH gene and to methods of treating or preventing an XDH-associated disease in a subject.
    Type: Application
    Filed: March 1, 2022
    Publication date: December 29, 2022
    Inventors: James D. McIninch, Jingxuan Liu, Mark K. Schlegel, Adam Castoreno, Anna Borodovsky
  • Publication number: 20220316385
    Abstract: Systems, methods and apparatus are disclosed for providing reduced engine start times for a fumigation type internal combustion engine. A bypass is provided that directly connects the air-fuel mixer upstream of the compressor to the intake manifold, providing the air-fuel mixture to the intake manifold during engine startup.
    Type: Application
    Filed: June 22, 2022
    Publication date: October 6, 2022
    Inventors: Rick Vaughan Lewis, JR., Yilun Liu, Jingxuan Liu, Trideep Singh, Carlos Alcides Lana, Stephen Cox
  • Publication number: 20220267767
    Abstract: The present invention relates to methods of use of RNAi agents, e.g., double stranded RNAi agents, targeting a Factor XII (Hageman Factor (F12) gene, for treating subjects having a contact activation pathway-associated disease, such as a thrombophilia or hereditary angioedema (HAE), methods for preventing at least one symptom in a subject having a contact activation pathway-associated disease, such as a thrombus formation or an angioedema attack, and RNAi agents targeting an F12 gene, for use in the methods of the invention.
    Type: Application
    Filed: September 28, 2021
    Publication date: August 25, 2022
    Inventors: James Butler, Jingxuan Liu
  • Publication number: 20220228151
    Abstract: The present invention relates to RNAi agents, e.g., double stranded RNA (dsRNA) agents, targeting the CPB2 gene. The invention also relates to methods of using such RNAi agents to inhibit expression of a CPB2 gene and to methods of preventing and treating a CPB2-associated disorder, e.g., a disorder associated with thrombosis.
    Type: Application
    Filed: January 31, 2022
    Publication date: July 21, 2022
    Inventors: Jingxuan Liu, James D. McIninch, Patrick Haslett
  • Publication number: 20220228144
    Abstract: The present invention relates to RNAi agents, e.g., double stranded RNA (dsRNA) agents, targeting the SERPINF2 gene. The invention also relates to methods of using such RNAi agents to inhibit expression of a SERPINF2 gene and to methods of preventing and treating a SERPINF2-associated disorder, e.g., a disorder associated with thrombosis.
    Type: Application
    Filed: January 31, 2022
    Publication date: July 21, 2022
    Inventors: Jingxuan Liu, James D. McIninch, Patrick Haslett
  • Patent number: 11326166
    Abstract: The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the xanthine dehydrogenase (XDH) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of an XDH gene and to methods of treating or preventing an XDH-associated disease in a subject.
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: May 10, 2022
    Assignee: Alnylam Pharmaceuticals, Inc.
    Inventors: James D. McIninch, Jingxuan Liu, Mark K. Schlegel, Adam Castoreno, Anna Borodovsky
  • Publication number: 20210246447
    Abstract: The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting the Kallikrein B, Plasma (Fletcher Factor) 1 (KLKB1) gene, the Factor XII (Hageman Factor (F12) gene, or the Kininogen 1 (KNG1) gene, and methods of using such RNAi agents to inhibit expression of a KLKB1 gene, an F12 gene, and/or a KNG1 gene, and methods of treating subjects having an hereditary angioedema (HAE) and/or a contact activation pathway-associated disorder.
    Type: Application
    Filed: December 15, 2020
    Publication date: August 12, 2021
    Inventors: Akin Akinc, Gregory Hinkle, Martin A. Maier, James Butler, Jingxuan Liu